Paragonix's donor heart transport system wins FDA nod

02/12/2013 | American City Business Journals

The FDA has given Paragonix Technologies 510(k) clearance for its Sherpa Pak Cardiac Transport System to be used in preserving donor hearts in transit for as long as four hours. The device uses oxygenated perfusion and cold storage technology, and the company hopes it will eventually be cleared to keep donor hearts alive for up to 12 hours.

View Full Article in:

American City Business Journals

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT